Amol Akhade/hiranandanihospital.org
Jul 18, 2025, 17:01
Amol Akhade: Want to Raise a Critical Point on a Published Clinical Trial?
Amol Akhade, Consultant Medical Oncologist at Suyog Cancer Clinics, shared a post on X:
“Want to raise a critical point on a published clinical trial?
What actually works to reach right people and spark discussion?
- Letter to the Editor – 95% desk rejection (especially if it’s a sponsored trial…)
- Post on X or LinkedIn – wider audience, real engagement
- Try both – submit letter if rejected, post it as an open letter on X .
- Forget it – read, think, move on- repeat
What’s your go-to strategy? Vote and discuss.”
According to the responses:
- 11.2% of participants preferred raising their critical point by writing a formal Letter to the Editor.
- 37.4% chose to share their perspective publicly through a post on platforms like X or LinkedIn.
- 35.5% believed in combining both approaches—submitting a Letter to the Editor while also posting on social media to reach a wider audience.
- 15.9% indicated they would simply read, reflect on the issue, and ultimately move on without taking further action.
More posts featuring Amol Akhade.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jul 18, 2025, 17:01
Jul 18, 2025, 16:52
Jul 18, 2025, 16:51
Jul 18, 2025, 16:43
Jul 18, 2025, 16:39
Jul 18, 2025, 16:37
Jul 18, 2025, 16:05